全球血气监测系统市场规模（依产品类型、最终用户、地区、范围和预测）

血气监测系统的市场规模及预测

2024 年血气监测系统市场规模价值 43.2 亿美元，预计到 2031 年将达到 68.3 亿美元，2024 年至 2031 年的复合年增长率为 5.88%。推动市场发展的关键因素是老年人口的增加和慢性病发病率的上升，从而促使住院人数的增加。全球血气监测系统市场报告对市场进行了全面的评估。它对关键细分市场、趋势、市场推动因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

血气监测系统全球市场定义

血气监测仪是一种测量血液中氧气、二氧化碳和酸含量的设备。这些因素有助于诊断肺部疾病、休克和药物过量等疾病。根据美国国家生物技术资讯中心（NCBI）的数据，血气监测设备对于医院重症监护病房（ICU）和心臟监护病房（CCU）至关重要。检测患者的动脉血气（ABG）对于确定和维持患者的氧合状态和酸碱平衡至关重要。

此诊断工具的有效性取决于对结果的正确解释。酸碱失衡会促使各种疾病的併发症，有时这些异常会变得严重到成为危及生命的危险因子。所有医生，包括重症监护医生和麻醉师，都应该彻底瞭解酸碱平衡。 HCO3-（相对于 pCO2）、标准碱过剩（SBE）和强离子差异（SID）是酸碱生理学（SID）中最广泛使用的三种方法。

Stewart 的 SID 概念已存在 20 多年，其定义为完全解离的阴离子和阳离子之间的绝对差异。动脉血气监测是确定患者氧合、通气和酸碱状态的首选方法。儘管非侵入性监测已在很大程度上取代了 ABG 监测，但 ABG 监测对于验证和校准非侵入性监测方法仍然很有价值。脉搏血氧仪测量的血氧饱和度 (SpO2) 与实验室血氧仪测量的 SaO2 不一样。

脉搏血氧仪测量血红素的功能饱和度。以还原血红素和氧合血红素总和的百分比来表示的氧合血红素的量称为功能饱和度。实验室氧饱和度计使用不同的波长来区分不同形式的血红蛋白（高铁血红蛋白和碳氧血红蛋白），从而确定净饱和分数，或含氧血红蛋白占总还原血红蛋白的百分比。

血气监测系统全球市场概况

对自动化临床血气分析仪的需求不断增加是市场扩张的主要驱动力。这些分析仪能够快速提供结果，易于使用、便于携带且週转时间短，使其成为管理 ICU 和急诊室氧合和通气的必备工具。推动血液气体监测系统市场成长的其他因素包括老年人口的增加和慢性病盛行率的上升、技术先进的生物感测器和数据分析软体的采用率不断提高以及技术整合综合体数量的增加。的需求和POC血气分析仪的小型化不断增加。

此外，血气分析仪与电子病历和实验室资讯系统的整合正在创造市场扩张的机会。这些整合技术不仅可以更好地监测患者，而且还有助于简化工作流程。但由于即时诊断设备和血气监测设备成本较高且部分国家监管要求严格，市场扩张受到限制。脉搏血氧仪可用于ICU的间歇监测或即时连续血氧饱和度测量。在全身麻醉和机械通气期间，持续监测非常有益。对呼吸功能处于边缘状态的患者进行应激性操作（BAL、气管灌洗、离心）时，可以使用脉搏血氧饱和度测定来检测饱和度的变化。

帮助评估是否需要额外的氧气补充。此外，由于血流是脉搏的，脉搏血氧仪感测器的输出可以透过电子处理来提供脉搏波形和心率。因此，脉搏血氧仪可用于追踪週边脉搏的速率和规律。调节常量营养素（葡萄糖、蛋白质、脂肪）和微量营养素（维生素和微量元素）的供应，然后评估 这些能量需求和供应之间的充分性，最后控制血糖，是 ICU 营养和代谢护理的关键组成部分。是我们的三个主要目标。

这是一个至关重要的问题，因为越来越多的证据表明，蛋白质和能量供应不足以及血糖控制不佳都与 ICU 中的不良临床结果有关。 Alere（圣地牙哥）的企业护理点血液学系统是唯一使用智慧卡技术的无线床边侦测选项。这项尖端技术将患者的检查结果直接传输到 PDA（个人数位助理）和电子病历，使医生能够留在患者的床边。便携式设备由于易于使用、操作和维护而具有较高的接受率。一些新兴市场正在投资开发和销售此类设备。

目录

第 1 章全球血液气体监测系统市场：简介

市场概况
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第 4 章 血液气体监测系统全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 阻碍因素
  • 机会
• 波特五力模型
• 价值链分析

第 5 章全球血气监测系统市场依产品类型

• 概述
• 桌面型
• 便携型

第6章 全球血气监测系统市场（依最终使用者）

• 概述
• 医院
• 心导管室
• 诊断中心
• 门诊手术中心
• 其他

第7章 全球血液气体监测系统市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第 8 章全球血液气体监测系统市场：竞争格局

• 概述
• 各公司的市场排名
• 主要发展策略

第9章 公司简介

• Abbott Laboratories
• Alere, Inc.
• Instrumentation Laboratory
• Medicacorp
• Optimedical
• Radiometer
• Roche Diagnostics
• SenTec AG
• Siemens Healthcare
• Sphere Medical

第10章 附录

• 关联调查

Blood Gas Monitoring Systems Market Size And Forecast

Blood Gas Monitoring Systems Market size was valued at USD 4.32 Billion in 2024 and is projected to reach USD 6.83 Billion by 2031, growing at a CAGR of 5.88% from 2024 to 2031 The primary factor driving the market is the growing elderly population and the rising frequency of chronic diseases, which leads to an increase in hospital admissions. The Global Blood Gas Monitoring Systems Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market

Global Blood Gas Monitoring Systems Market Definition

Blood gas monitors are instruments that measure the amount of oxygen, carbon dioxide, and acidity in the bloodstream. These factors contribute to the diagnosis of diseases such as lung disorders, shock, and drug overdoses, among others. According to the National Center for Biotechnology Information (NCBI), for intensive care units (ICU) and Cardiac Care Unit (CCU) rooms in the hospital, blood gas monitoring equipment is essential. The examination of a patient's arterial blood gas (ABG) is crucial for identifying and maintaining their oxygenation status and acid-base balance.

The effectiveness of this diagnostic tool is contingent on the ability to interpret the results appropriately. Acid-base imbalances can cause complications in a variety of diseases, and the aberration can sometimes be so severe that it becomes a life-threatening risk factor. Any physician, including an intensivist and an anesthesiologist, must have a good understanding of acid-base balance. The HCO3- (in the context of pCO2), standard base excess (SBE), and strong ion difference (SID) are the three most extensively utilized approaches to acid-base physiology (SID).

Stewart's idea of SID, which is defined as the absolute difference between totally dissociated anions and cations, has been around for more than 20 years. For determining a patient's oxygenation, ventilation, and acid-base status, arterial blood gas monitoring is the preferred method. Despite the fact that non-invasive monitoring has mostly supplanted ABG monitoring, it is still valuable for validating and calibrating non-invasive monitoring approaches. The oxygen saturation measured by a pulse oximeter (SpO2) and the SaO2 measured by a laboratory cooximeter is not the same.

The functional saturation of hemoglobin is measured by the pulse oximeter. The amount of oxygenated hemoglobin in a percentage form of total reduced and oxygenated hemoglobin is known as functional saturation. Cooximeters in laboratories uses various wavelengths to discriminate between different forms of hemoglobin (methemoglobin and carboxyhemoglobin) and so quantify genuine fractional saturation, or the amount of oxygenated hemoglobin in a percentage form of the total reduced.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Blood Gas Monitoring Systems Market Overview

The increased demand for automated and point-of-care blood gas analyzer devices is mostly responsible for the market's expansion. These analyzers provide quick results, are simple to use, portable, and have quick turnaround times, making them essential tools for managing oxygenation and ventilation in ICUs and emergency rooms. Other factors driving the growth of the Blood Gas Monitoring Systems Market include an older population and an increase in the prevalence of chronic diseases, increased adoption of technologically advanced biosensors and data analysis software, increasing demand for technology-integrated combined systems, and miniaturization of POC blood gas analyzers.

In addition, the integration of blood gas analyzers with electronic medical records and laboratory information systems is presenting a profitable opportunity for market expansion. These integrated technologies not only allow for excellent patient monitoring but also help to streamline the workflow. However, high prices for point-of-care devices and blood gas monitors, as well as severe regulatory requirements in some countries, limit market expansion. The pulse oximeter can be used in the ICU for intermittent monitoring or to offer a continuous real-time oxygen saturation reading. During general anesthesia or ventilation, continuous monitoring is very beneficial. When stressful treatments are performed on patients with borderline respiratory function (BALs, tracheal washes, centesis), the pulse oximeter can be utilized to detect changes in saturation.

It can help us assess whether or not more oxygen supplementation is required. Furthermore, because blood flow is pulsatile, the pulse oximeter sensor's output can be electronically processed to provide a pulse waveform and heart rate. As a result, the pulse oximeter can be used to track the rate and regularity of peripheral pulses. The regulation of macronutrients (glucose, protein, fat) and micronutrients (vitamins and trace elements) delivery, second, the assessment of the adequacy between energy needs and delivery, and finally, glycaemic control are the three primary goals of nutritional and metabolic care in the ICU.

This is a critical issue since a large body of evidence shows that inadequate protein and energy coverage, as well as poor glycemic management, are both linked to a poor clinical outcome in the ICU. The Alere (San Diego) Enterprise Point of Care blood analysis system is the only wireless bedside testing option that employs Smartcard technology. This cutting-edge technology sends patient results straight to a personal digital assistant (PDA) and the electronic medical record, allowing the doctor to remain at the patient's bedside. The portable devices are simple to use, handle, and maintain, which contributes to their higher acceptance rate. Several businesses are making investments in the development and marketing of these items. Though portable devices have an advantage over traditional devices.

Global Blood Gas Monitoring Systems Market Segmentation Analysis

The Global Blood Gas Monitoring Systems Market is Segmented on the basis of Product Type, End-User, And Geography.

Blood Gas Monitoring Systems Market, By Product Type

• Desktop Type
• Portable Type

Based on Product Type, The market is segmented into Desktop Type and Portable Type. There are numerous advantages to using an LED monitor. The biggest advantage is that they offer the highest image quality currently available. In general, a patient monitoring device consists of a sensor for gathering critical patient data (e.g., heart rate) and an interconnect solution (e.g., PCBs, connectors, wire, etc.) for transmitting the data to the capital equipment. The patient monitoring device component of a pulse oximeter, for example, is the piece that clips to your finger and senses and communicates your pulse to the capital equipment.

Blood Gas Monitoring Systems Market, By End-User

• Hospitals
• Cardiac Catheterization Laboratory
• Diagnostic Centers
• Ambulatory Surgical Centers
• Others

Based on End-User, The market is segmented into Hospitals, Cardiac Catheterization Laboratory, Diagnostic Centers, Ambulatory Surgical Centers, Others. A hospital is a medical facility that treats patients with specialized health science and auxiliary healthcare personnel as well as medical equipment. Doctors use catheters instead of surgery to diagnose and treat heart diseases in the cardiac catheterization laboratory. A catheterization lab, rather than an operating room, can safely perform a variety of procedures. Catheters are plastic tubes that resemble spaghetti and are used to introduce special devices to diagnose or treat heart problems.

Blood Gas Monitoring Systems Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, The Global Blood Gas Monitoring Systems Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. he Asia Pacific region is expected to witness a significant CAGR during the forecast period. This is primarily due to the primary factor driving the market is the growing elderly population and the rising frequency of chronic diseases, which leads to an increase in hospital admissions.

Key Players

• The "Global Blood Gas Monitoring Systems Market" study report will provide a valuable insight with an emphasis on the global market including some of the major players such as
• Abbott Laboratories, Alere, Inc, Instrumentation Laboratory, Mediacorp, Optimedical, Radiometer, Roche Diagnostics, SenTec AG, Siemens Healthcare, Sphere Medical.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• November 2020, In India, Abbott launched the FreeStyle Blood Glucose Monitor for diabetic adults and children (over the age of four) as well as women with gestational diabetes (diabetes during pregnancy).
• November 2021, Abbott released late-breaking data from the global Leadless II IDE study, which looked at Abbott's investigational Aveir leadless pacemaker in people with specific irregular heart rhythms.
• Jan 2019, Perimed AB and Radiometer Medical ApS have partnered to accelerate and increase the marketing of Perimed's PeriFlux 6000 CPO 2 standalone system.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL BLOOD GAS MONITORING SYSTEMS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL BLOOD GAS MONITORING SYSTEMS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL BLOOD GAS MONITORING SYSTEMS MARKET, PRODUCT TYPE

• 5.1 Overview
• 5.2 Desktop Type
• 5.3 Portable Type

6 GLOBAL BLOOD GAS MONITORING SYSTEMS MARKET, BY END-USER

• 6.1 Overview
• 6.2 Hospitals
• 6.3 Cardiac Catheterization Laboratory
• 6.4 Diagnostic Centers
• 6.5 Ambulatory Surgical Centers
• 6.6 Others

7 GLOBAL BLOOD GAS MONITORING SYSTEMS MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL BLOOD GAS MONITORING SYSTEMS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Abbott Laboratories
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Alere, Inc.
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Instrumentation Laboratory
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Medicacorp
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Optimedical
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Radiometer
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Roche Diagnostics
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 SenTec AG
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Siemens Healthcare
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Sphere Medical
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research